Cerity Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Cerity Partners's ACLS Position: Q2 2026 in Review
Cerity Partners increased its Axcelis (ACLS) stake by 100% in Q2 2026, buying an estimated $485K and bringing the position to 6,533 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1867.
Cerity Partners first reported a position in ACLS in Q4 2022 and has held it in 14 quarters since. The position peaked at $11.4M in Q2 2024. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Cerity Partners held 6,533 shares of Axcelis worth $1.24M as of Q2 2026.
- Cerity Partners bought 3,270 Axcelis shares in Q2 2026, an estimated $485K.
- Axcelis made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1867 holding.
- Cerity Partners first reported a position in Axcelis in Q4 2022 and has held it in 14 quarters since.
- Cerity Partners's Axcelis position peaked at $11.4M in Q2 2024.
- 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.